1.
2.
3.
Adeno-associated virus (AAV) based in vivo gene therapy has made great progress in recent years including an approved treatment (Glybera) in Europe and several [...]
2016-04-01 | Dissertation |
4.
Adeno-­‐associated virus (AAV) is a leading candidate as a gene therapy vector, but as with other vectors, one of the limitations is a host-neutralizing immune response.
2012-05-01 | Dissertation |
5.
This dissertation describes the development of the TRADE system for directed evolution of the AAV capsid, its successful application to identify the HN1 variant, a novel [...]
2021 | Dissertation |